Line 4: |
Line 4: |
| | | |
| == Common Adult Cancers == | | == Common Adult Cancers == |
− | #[[AML|Acute Myeloid Leukemia]] | + | #[[:Category:AML|Acute Myeloid Leukemia]] |
| #[[:Category:Kidney|Neoplasms of the Kidney]] | | #[[:Category:Kidney|Neoplasms of the Kidney]] |
| + | #[[:Category:Brain|Neoplasms of the Brain and CNS]] |
| | | |
| == Common Pediatric Cancers == | | == Common Pediatric Cancers == |
Line 295: |
Line 296: |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
| : Malignant epithelial tumours | | : Malignant epithelial tumours |
− | : Squamous cell carcinoma | + | : [[Squamous cell carcinoma]] |
− | : Lymphoepithelial carcinoma | + | : [[Lymphoepithelial carcinoma]] |
− | : Sinonasal undifferentiated carcinoma | + | : [[Sinonasal undifferentiated carcinoma]] |
− | : Adenocarcinoma | + | : [[Adenocarcinoma]] |
− | : Salivary gland-type carcinomas | + | : [[Salivary gland-type carcinomas]] |
− | : Neuroendocrine tumours | + | : [[Neuroendocrine tumours]] |
− | : Benign epithelial tumours | + | : [[Benign epithelial tumours]] |
− | : Schneiderian papillomas | + | : [[Schneiderian papillomas]] |
− | : Respiratory epithelial adenomatoid hamartoma | + | : [[Respiratory epithelial adenomatoid hamartoma]] |
− | : Salivary gland-type adenomas | + | : [[Salivary gland-type adenomas]] |
− | : Soft tissue tumours | + | : [[Soft tissue tumours]] |
− | : Malignant soft tissue tumours | + | : [[Malignant soft tissue tumours]] |
− | : Borderline and LMP tumours | + | : [[Borderline and LMP tumours]] |
− | : Benign soft tissue tumours | + | : [[Benign soft tissue tumours]] |
− | : Tumours of bone and cartilage | + | : [[Tumours of bone and cartilage]] |
− | : Malignant tumours | + | : [[Malignant tumours]] |
− | : Benign tumours | + | : [[Benign tumours]] |
− | : Haematolymphoid tumours | + | : [[Haematolymphoid tumours]] |
− | : Neuroectodermal tumours | + | : [[Neuroectodermal tumours]] |
− | : Germ cell tumours | + | : [[Germ cell tumours]] |
− | : Secondary tumours | + | : [[Secondary tumours]] |
| </div> | | </div> |
| </div> | | </div> |
Line 646: |
Line 647: |
| '''Special subtypes''' | | '''Special subtypes''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Invasive lobular carcinoma | + | : [[Invasive lobular carcinoma]] |
− | : Tubular carcinoma and cribriform carcinoma | + | : [[Tubular carcinoma]] and [[cribriform carcinoma]] |
− | : Carcinoma with medullary features | + | : [[Carcinoma with medullary features]] |
− | : Metaplastic carcinoma | + | : [[Metaplastic carcinoma]] |
− | : Carcinoma with apocrine differentiation | + | : [[Carcinoma with apocrine differentiation]] |
− | : Salivary gland/skin adnexal type tumors | + | : [[Salivary gland/skin adnexal type tumors]] |
− | : Adenoid cystic carcinoma | + | : [[Adenoid cystic carcinoma]] |
− | : Mucoepidermoid carcinoma | + | : [[Mucoepidermoid carcinoma]] |
− | : Polymorphous carcinoma | + | : [[Polymorphous carcinoma]] |
− | : Mucinous carcinoma and carcinoma with | + | : [[Mucinous carcinoma]] and [[Carcinoma with signet-ring-cell differentiation]] |
− | : Ssignet-ring-cell differentiation carcinoma with neuroendocrine features
| + | : [[Carcinoma with neuroendocrine features]] |
− | : Invasive papillary carcinoma | + | : [[Invasive papillary carcinoma]] |
− | : Invasive micropapillary carcinoma | + | : [[Invasive micropapillary carcinoma]] |
− | : Inflammatory carcinoma | + | : [[Inflammatory carcinoma]] |
| : Bilateral breast carcinoma and non-synchronous breast carcinoma | | : Bilateral breast carcinoma and non-synchronous breast carcinoma |
− | : Secretory carcinoma | + | : [[Secretory carcinoma]] |
− | : Oncocytic carcinoma | + | : [[Oncocytic carcinoma]] |
− | : Sebaceous carcinoma | + | : [[Sebaceous carcinoma]] |
− | : Lipid-rich carcinoma | + | : [[Lipid-rich carcinoma]] |
− | : Glycogen-rich clear cell carcinoma | + | : [[Glycogen-rich clear cell carcinoma]] |
− | : Acinic cell carcinoma | + | : [[Acinic cell carcinoma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 678: |
Line 679: |
| : Columnar cell lesions | | : Columnar cell lesions |
| : Atypical ductal hyperplasia | | : Atypical ductal hyperplasia |
− | : Ductal carcinoma in situ | + | : [[Ductal carcinoma in situ]] |
| </div> | | </div> |
| </div> | | </div> |
Line 687: |
Line 688: |
| '''Intraductal papillary lesions''' | | '''Intraductal papillary lesions''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Intraductal papilloma | + | : [[Intraductal papilloma]] |
− | : Intraductal papillary carcinoma | + | : [[Intraductal papillary carcinoma]] |
− | : Encapsulated papillary carcinoma | + | : [[Encapsulated papillary carcinoma]] |
− | : Solid papillary carcinoma | + | : [[Solid papillary carcinoma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 697: |
Line 698: |
| '''Benign epithelial proliferations''' | | '''Benign epithelial proliferations''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Adenosis, sclerosing adenosis and | + | : Adenosis, sclerosing adenosis and apocrine adenosis |
− | : apocrine adenosis
| + | : [[Microglandular adenosis]],[[atypical microglandular adenosis and microglandular adenosis with carcinoma]] |
− | : Microglandular adenosis, | + | : [[Radial scar and complex sclerosing lesion]] |
− | : atypical microglandular adenosis and
| + | : [[Tubular adenoma]] |
− | : microglandular adenosis with carcinoma
| |
− | : Radial scar and complex sclerosing lesion | |
− | : Tubular adenoma | |
| : Lactating adenoma | | : Lactating adenoma |
| : Apocrine adenoma | | : Apocrine adenoma |
Line 714: |
Line 712: |
| '''Myoepithelial and epithelial–myoepithelial lesions''' | | '''Myoepithelial and epithelial–myoepithelial lesions''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Myoepithelial and epithelial–myoepithelial lesions | + | : [[Myoepithelial and epithelial–myoepithelial lesions]] |
− | : Adenomyoepithelioma and adenomyoepithelioma with carcinoma | + | : [[Adenomyoepithelioma and adenomyoepithelioma with carcinoma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 724: |
Line 722: |
| : Nodular fasciitis | | : Nodular fasciitis |
| : Benign vascular lesions | | : Benign vascular lesions |
− | : Pseudoangiomatous stromal hyperplasia | + | : [[Pseudoangiomatous stromal hyperplasia]] |
− | : Myofibroblastoma | + | : [[Myofibroblastoma]] |
− | : Desmoid-type fibromatosis | + | : [[Desmoid-type fibromatosis]] |
| : Inflammatory myofibroblastic tumour | | : Inflammatory myofibroblastic tumour |
| : Lipoma | | : Lipoma |
| : Granular cell tumour and benign peripheral | | : Granular cell tumour and benign peripheral |
| : nerve-sheath tumour | | : nerve-sheath tumour |
− | : Angiosarcoma | + | : [[Angiosarcoma]] |
| : Liposarcoma | | : Liposarcoma |
| : Rhabdomyosarcoma | | : Rhabdomyosarcoma |
Line 742: |
Line 740: |
| '''Fibroepithelial tumors''' | | '''Fibroepithelial tumors''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Fibroadenoma | + | : [[Fibroadenoma]] |
− | : Phyllodes tumour | + | : [[Phyllodes tumour]] |
| : Hamartoma | | : Hamartoma |
| </div> | | </div> |
Line 753: |
Line 751: |
| : Nipple adenoma | | : Nipple adenoma |
| : Syringomatous tumour | | : Syringomatous tumour |
− | : Paget disease | + | : [[Paget disease]] |
| </div> | | </div> |
| </div> | | </div> |
Line 760: |
Line 758: |
| '''Lymphoid and haematopoietic tumors''' | | '''Lymphoid and haematopoietic tumors''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Diffuse large B-cell lymphoma | + | : [[Diffuse large B-cell lymphoma]] |
| : Burkitt lymphoma | | : Burkitt lymphoma |
| : T-cell lymphoma | | : T-cell lymphoma |
Line 773: |
Line 771: |
| '''Tumors of the male breast''' | | '''Tumors of the male breast''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | : Gynaecomastia | + | : [[Gynaecomastia]] |
− | : Carcinoma of the male breast | + | : [[Carcinoma of the male breast]] |
| </div> | | </div> |
| </div> | | </div> |
Line 782: |
Line 780: |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
| : Inherited syndromes associated with an increased risk of breast cancer: Introduction | | : Inherited syndromes associated with an increased risk of breast cancer: Introduction |
− | : BRCA1 and BRCA2 syndromes | + | : [[BRCA1 symdrome]] and [[BRCA2 syndrome]] |
− | : Li-Fraumeni syndrome | + | : [[Li-Fraumeni syndrome]] |
| : Ataxia telangiectasia syndrome | | : Ataxia telangiectasia syndrome |
| : Cowden syndrome | | : Cowden syndrome |
Line 797: |
Line 795: |
| == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == | | == WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues (2008) == |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Hematological and Lymphoid Neoplasms''' | + | '''[[Hematological and Lymphoid Neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
| | | |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Myeloproliferative neoplasms''' | + | '''[[Myeloproliferative neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Chronic myelogenous leukaemia, BCR-ABL1 positive | + | :[[Chronic myelogenous leukaemia, BCR-ABL1 positive]] |
− | :Chronic neutrophilic leukaemia | + | :[[Chronic neutrophilic leukaemia]] |
− | :Polycythaemia vera | + | :[[Polycythaemia vera]] |
− | :Primary myelofibrosis | + | :[[Primary myelofibrosis]] |
− | :Essential thrombocythaemia | + | :[[Essential thrombocythaemia]] |
− | :Chronic eosinophilic leukaemia, NOS | + | :[[Chronic eosinophilic leukaemia, NOS]] |
− | :Mastocytosis | + | :[[HAEM4:Mastocytosis]] |
− | :Cutaneous mastocytosis | + | :[[Cutaneous mastocytosis]] |
− | :Systemic mastocytosis | + | :[[Systemic mastocytosis]] |
− | :Mast cell leukaemia | + | :[[Mast cell leukaemia]] |
− | :Mast cell sarcoma | + | :[[Mast cell sarcoma]] |
− | :Extracutaneous mastocytoma | + | :[[Extracutaneous mastocytoma]] |
− | :Myeloproliferative neoplasm, unclassifiable | + | :[[Myeloproliferative neoplasm, unclassifiable]] |
| </div> | | </div> |
| </div> | | </div> |
− | '''Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1''' | + | '''[[Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA,PDGFRB or FGFR1]] |
| + | ''' |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Myelodysplastic/myeloproliferative neoplasms''' | + | '''[[Myelodysplastic/myeloproliferative neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Chronic myelomonocytic leukaemia | + | :[[Chronic myelomonocytic leukaemia]] |
− | :Atypical chronic myeloid leukaemia, BCR-ABL1 negative | + | :[[Atypical chronic myeloid leukaemia, BCR-ABL1 negative]] |
− | :Juvenile myelomonocytic leukaemia | + | :[[Juvenile myelomonocytic leukaemia]] |
− | :Myelodysplastic/myeloproliferative neoplasm, unclassifiable | + | :[[Myelodysplastic/myeloproliferative neoplasm, unclassifiable]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Myelodysplastic syndromes''' | + | '''[[Myelodysplastic syndromes]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Myelodysplastic syndromes/neoplasms, overview | + | :[[Myelodysplastic syndromes/neoplasms, overview]] |
− | :Refractory cytopenia with unilineage dysplasia | + | :[[Refractory cytopenia with unilineage dysplasia]] |
− | :Refractory anaemia with ring sideroblasts | + | :[[Refractory anaemia with ring sideroblasts]] |
− | :Refractory cytopenia with multilineage dysplasia | + | :[[Refractory cytopenia with multilineage dysplasia]] |
− | :Refractory anaemia with excess blasts | + | :[[Refractory anaemia with excess blasts]] |
− | :Myelodysplastic syndrome with isolated del(5q) | + | :[[Myelodysplastic syndrome with isolated del(5q)]] |
− | :Myelodysplastic syndrome, unclassifiable | + | :[[Myelodysplastic syndrome, unclassifiable]] |
− | :Childhood myelodysplastic syndrome | + | :[[Childhood myelodysplastic syndrome]] |
− | :Refractory cytopenia of childhood | + | :[[Refractory cytopenia of childhood]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Acute myeloid leukaemia (AML) and related precursor neoplasms''' | + | '''[[Acute myeloid leukaemia (AML) and related precursor neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :AML with recurrent genetic abnormalities | + | :[[AML with recurrent genetic abnormalities]] |
− | :AML with t(8;21)(q22;q22); RUNX1-RUNX1T1 | + | :[[AML with t(8;21)(q22;q22); RUNX1-RUNX1T1]] |
− | :AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11 | + | :[[AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11]] |
− | :Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA | + | :[[Acute promyelocytic leukaemia with t(15;17)(q22;q12); PML-RARA]] |
− | :AML with t(9;11)(p22;q23); MLLT3-MLL | + | :[[AML with t(9;11)(p22;q23); MLLT3-MLL]] |
− | :AML with t(6;9)(p23;q34); DEK-NUP214 | + | :[[AML with t(6;9)(p23;q34); DEK-NUP214]] |
− | :AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1 | + | :[[AML with inv(3)(q21q26.2) or t(3;3)(q21;q26.2);RPN1-EVI1]] |
− | :AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1 | + | :[[AML (megakaryoblastic) with t(1;22)(p13;q13);RBM15-MKL1]] |
− | :AML with mutated NPM1 | + | :[[AML with mutated NPM1]] |
− | :AML with mutated CEBPA | + | :[[AML with mutated CEBPA]] |
− | :AML with myelodysplasia-related changes | + | :[[AML with myelodysplasia-related changes]] |
− | :Therapy-related myeloid neoplasms | + | :[[Therapy-related myeloid neoplasms]] |
− | :Acute myeloid leukaemia, NOS | + | :[[Acute myeloid leukaemia, NOS]] |
− | :AML with minimal differentiation | + | :[[AML with minimal differentiation]] |
− | :AML without maturation | + | :[[AML without maturation]] |
− | :AML with maturation | + | :[[AML with maturation]] |
− | :Acute myelomonocytic leukaemia | + | :[[Acute myelomonocytic leukaemia]] |
− | :Acute monoblastic and monocytic leukaemia | + | :[[Acute monoblastic and monocytic leukaemia]] |
− | :Acute erythroid leukaemia | + | :[[Acute erythroid leukaemia]] |
− | :Acute megakaryoblastic leukaemia | + | :[[Acute megakaryoblastic leukaemia]] |
− | :Acute basophilic leukaemia | + | :[[Acute basophilic leukaemia]] |
− | :Acute panmyelosis with myelofibrosis | + | :[[Acute panmyelosis with myelofibrosis]] |
− | :Myeloid sarcoma | + | :[[Myeloid sarcoma]] |
− | :Myeloid proliferations related to Down syndrome | + | :[[Myeloid proliferations related to Down syndrome]] |
− | :Transient abnormal myelopoiesis | + | :[[Transient abnormal myelopoiesis]] |
− | :Myeloid leukaemia associated with Down syndrome | + | :[[Myeloid leukaemia associated with Down syndrome]] |
− | :Blastic plasmacytoid dendritic cell neoplasm | + | :[[Blastic plasmacytoid dendritic cell neoplasm]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Acute leukaemias of ambiguous lineage''' | + | '''[[Acute leukaemias of ambiguous lineage]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Acute undifferentiated leukaemia | + | :[[Acute undifferentiated leukaemia]] |
− | :Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1 | + | :[[Mixed phenotype acute leukaemia with t(9;22)(q34;q11.2); BCR-ABL1]] |
− | :Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged | + | :[[Mixed phenotype acute leukaemia with t(v;11q23); MLL rearranged]] |
− | :Mixed phenotype acute leukaemia, B/myeloid, NOS 152 | + | :[[Mixed phenotype acute leukaemia, B/myeloid, NOS]] 152 |
− | :Mixed phenotype acute leukaemia, T/myeloid, NOS 153 | + | :[[Mixed phenotype acute leukaemia, T/myeloid, NOS]] 153 |
− | :Mixed phenotype acute leukaemia, NOS - rare types | + | :[[Mixed phenotype acute leukaemia, NOS - rare types]] |
− | :Other ambiguous lineage leukaemias | + | :[[Other ambiguous lineage leukaemias]] |
− | :Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma | + | :[[Natural killer (NK)-cell lymphoblastic leukaemia/lymphoma]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Precursor lymphoid neoplasms''' | + | '''[[Precursor lymphoid neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :B lymphoblastic leukaemia/lymphoma, NOS | + | :[[B lymphoblastic leukaemia/lymphoma, NOS]] |
− | :B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities | + | :[[B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities]] |
− | :B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1 | + | :[[B lymphoblastic leukaemia/lymphoma with t(9:22)(q34;q11.2); BCR-ABL1]] |
− | :B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged | + | :[[B lymphoblastic leukaemia/lymphoma with t(v;11q23); MLL rearranged]] |
− | :B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(12;21)(p13;q22); TEL-AML1 (ETV6-RUNX1)]] |
− | :B lymphoblastic leukaemia/lymphoma with hyperdiploidy | + | :[[B lymphoblastic leukaemia/lymphoma with hyperdiploidy]] |
− | :B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL) | + | :[[B lymphoblastic leukaemia/lymphoma with hypodiploidy (Hypodiploid ALL)]] |
− | :B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH | + | :[[B lymphoblastic leukaemia/lymphoma with t(5;14)(q31;q32); IL3-IGH]] |
− | :B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1) | + | :[[B lymphoblastic leukaemia/lymphoma with t(1;19) (q23;p13.3); E2A-PBX1(TCF3-PBX1)]] |
− | :T lymphoblastic leukaemia/lymphoma | + | :[[T lymphoblastic leukaemia/lymphoma]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Mature B-cell neoplasms''' | + | '''[[Mature B-cell neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Chronic lymphocytic leukaemia /small lymphocytic lymphoma | + | :[[Chronic lymphocytic leukaemia /small lymphocytic lymphoma]] |
− | :B-cell prolymphocytic leukaemia | + | :[[B-cell prolymphocytic leukaemia]] |
− | :Splenic marginal zone lymphoma | + | :[[Splenic marginal zone lymphoma]] |
− | :Hairy cell leukaemia | + | :[[Hairy cell leukaemia]] |
− | :Splenic B-cell lymphoma/leukaemia, unclassifiable | + | :[[Splenic B-cell lymphoma/leukaemia, unclassifiable]] |
− | :Splenic diffuse red pulp small B-cell lymphoma | + | :[[Splenic diffuse red pulp small B-cell lymphoma]] |
− | :Hairy cell leukaemia-variant | + | :[[Hairy cell leukaemia-variant]] |
− | :Lymphoplasmacytic lymphoma | + | :[[Lymphoplasmacytic lymphoma]] |
− | :Heavy chain diseases | + | :[[Heavy chain diseases]] |
− | :Gamma heavy chain disease | + | :[[Gamma heavy chain disease]] |
− | :Mu heavy chain disease | + | :[[Mu heavy chain disease]] |
− | :Alpha heavy chain disease | + | :[[Alpha heavy chain disease]] |
− | :Plasma cell neoplasms | + | :[[Plasma cell neoplasms]] |
− | :Monoclonal gammopathy of undetermined significance (MGUS) | + | :[[Monoclonal gammopathy of undetermined significance (MGUS)]] |
− | :Plasma cell myeloma | + | :[[Plasma cell myeloma]] |
− | :Solitary plasmacytoma of bone | + | :[[Solitary plasmacytoma of bone]] |
− | :Extraosseous plasmacytoma | + | :[[Extraosseous plasmacytoma]] |
− | :Monoclonal immunoglobulin deposition diseases | + | :[[Monoclonal immunoglobulin deposition diseases]] |
− | :Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma) | + | :[[Extranodal marginal zone lymphoma of mucosa- associated lymphoid tissue (MALT lymphoma)]] |
− | :Nodal marginal zone lymphoma | + | :[[Nodal marginal zone lymphoma]] |
− | :Follicular lymphoma | + | :[[Follicular lymphoma]] |
− | :Primary cutaneous follicle centre lymphoma | + | :[[Primary cutaneous follicle centre lymphoma]] |
− | :Mantle cell lymphoma | + | :[[Mantle cell lymphoma]] |
− | :Diffuse large B-cell lymphoma (DLBCL), NOS | + | :[[Diffuse large B-cell lymphoma (DLBCL), NOS]] |
− | :T cell/histiocyte-rich large B-cell lymphoma | + | :[[T cell/histiocyte-rich large B-cell lymphoma]] |
− | :Primary DLBCL of the CNS | + | :[[Primary DLBCL of the CNS]] |
− | :Primary cutaneous DLBCL, leg type | + | :[[Primary cutaneous DLBCL, leg type]] |
− | :EBV positive DLBCL of the elderly | + | :[[EBV positive DLBCL of the elderly]] |
− | :DLBCL associated with chronic inflammation | + | :[[DLBCL associated with chronic inflammation]] |
− | :Lymphomatoid granulomatosis | + | :[[Lymphomatoid granulomatosis]] |
− | :Primary mediastinal (thymic) large B-cell lymphoma | + | :[[Primary mediastinal (thymic) large B-cell lymphoma]] |
− | :Intravascular large B-cell lymphoma | + | :[[Intravascular large B-cell lymphoma]] |
− | :ALK positive large B-cell lymphoma | + | :[[ALK positive large B-cell lymphoma]] |
− | :Plasmablastic lymphoma | + | :[[Plasmablastic lymphoma]] |
− | :Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease | + | :[[Large B-cell lymphoma arising in HHV8-associated multicentric Castleman disease]] |
− | :Primary effusion lymphoma | + | :[[Primary effusion lymphoma]] |
− | :Burkitt lymphoma | + | :[[Burkitt lymphoma]] |
− | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma]] |
− | :B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma | + | :[[B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and classical Hodgkin lymphoma]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Mature T- and NK-cell neoplasms''' | + | '''[[Mature T- and NK-cell neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :T-cell prolymphocytic leukaemia | + | :[[T-cell prolymphocytic leukaemia]] |
− | :T-cell large granular lymphocytic leukaemia | + | :[[T-cell large granular lymphocytic leukaemia]] |
− | :Chronic lymphoproliferative disorder of NK cells | + | :[[Chronic lymphoproliferative disorder of NK cells]] |
− | :Aggressive NK cell leukaemia | + | :[[Aggressive NK cell leukaemia]] |
− | :Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood | + | :[[Epstein-Barr virus (EBV) positive T-cell lymphoproliferative diseases of childhood]] |
− | :Systemic EBV+ T-cell lymphoproliferative disease of childhood | + | :[[Systemic EBV+ T-cell lymphoproliferative disease of childhood]] |
− | :Hydroa vacciniforme-like lymphoma | + | :[[Hydroa vacciniforme-like lymphoma]] |
− | :Adult T-cell leukaemia/lymphoma | + | :[[Adult T-cell leukaemia/lymphoma]] |
− | :Extranodal NK/T-cell lymphoma, nasal type | + | :[[Extranodal NK/T-cell lymphoma, nasal type]] |
− | :Enteropathy-associated T-cell lymphoma | + | :[[Enteropathy-associated T-cell lymphoma]] |
− | :Hepatosplenic T-cell lymphoma | + | :[[Hepatosplenic T-cell lymphoma]] |
− | :Subcutaneous panniculitis-like T-cell lymphoma | + | :[[Subcutaneous panniculitis-like T-cell lymphoma]] |
− | :Mycosis fungoides | + | :[[Mycosis fungoides]] |
− | :Sézary syndrome | + | :[[Sézary syndrome]] |
− | :Primary cutaneous CD30 positive T-cell lymphoproliferative disorders | + | :[[Primary cutaneous CD30 positive T-cell lymphoproliferative disorders]] |
− | :Primary cutaneous peripheral T-cell lymphomas, rare subtypes | + | :[[Primary cutaneous peripheral T-cell lymphomas, rare subtypes]] |
− | :Primary cutaneous gamma-delta T-cell lymphoma | + | :[[Primary cutaneous gamma-delta T-cell lymphoma]] |
− | :Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma | + | :[[Primary cutaneous CD8 positive aggressive epidermotropic cytotoxic T-cell lymphoma]] |
− | :Primary cutaneous CD4 positive small/medium T-cell lymphoma | + | :[[Primary cutaneous CD4 positive small/medium T-cell lymphoma]] |
− | :Peripheral T-cell lymphoma, NOS | + | :[[Peripheral T-cell lymphoma, NOS]] |
− | :Angioimmunoblastic T-cell lymphoma | + | :[[Angioimmunoblastic T-cell lymphoma]] |
− | :Anaplastic large cell lymphoma, ALK positive | + | :[[Anaplastic large cell lymphoma, ALK positive]] |
− | :Anaplastic large cell lymphoma, ALK negative | + | :[[Anaplastic large cell lymphoma, ALK negative]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Hodgkin lymphoma''' | + | '''[[Hodgkin lymphoma]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Nodular lymphocyte predominant Hodgkin lymphoma | + | :[[Nodular lymphocyte predominant Hodgkin lymphoma]] |
− | :Classical Hodgkin lymphoma | + | :[[Classical Hodgkin lymphoma]] |
− | :Nodular sclerosis classical Hodgkin lymphoma | + | :[[Nodular sclerosis classical Hodgkin lymphoma]] |
− | :Mixed cellularity classical Hodgkin lymphoma | + | :[[Mixed cellularity classical Hodgkin lymphoma]] |
− | :Lymphocyte-rich classical Hodgkin lymphoma | + | :[[Lymphocyte-rich classical Hodgkin lymphoma]] |
− | :Lymphocyte-depleted classical Hodgkin lymphoma | + | :[[Lymphocyte-depleted classical Hodgkin lymphoma]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Immunodeficiency-associated lymphoproliferative disorders''' | + | '''[[Immunodeficiency-associated lymphoproliferative disorders]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Lymphoproliferative diseases associated with primary immune disorders | + | :[[Lymphoproliferative diseases associated with primary immune disorders]] |
− | :Lymphomas associated with HIV infection | + | :[[Lymphomas associated with HIV infection]] |
− | :Post-transplant lymphoproliferative disorders (PTLD) | + | :[[Post-transplant lymphoproliferative disorders (PTLD)]] |
− | :Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD | + | :[[Plasmacytic hyperplasia and infectious- mononucleosis-like PTLD]] |
− | :Polymorphic PTLD | + | :[[Polymorphic PTLD]] |
− | :Monomorphic PTLD | + | :[[Monomorphic PTLD]] |
− | :Classical Hodgkin lymphoma type PTLD | + | :[[Classical Hodgkin lymphoma type PTLD]] |
− | :Other iatrogenic immunodeficiency-associated lymphoproliferative disorders | + | :[[Other iatrogenic immunodeficiency-associated lymphoproliferative disorders]] |
| </div> | | </div> |
| </div> | | </div> |
| <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> | | <div class="toccolours mw-collapsible mw-collapsed" style="width:800px"> |
− | '''Histiocytic and dendritic cell neoplasms''' | + | '''[[Histiocytic and dendritic cell neoplasms]]''' |
| <div class="mw-collapsible-content"> | | <div class="mw-collapsible-content"> |
− | :Histiocytic sarcoma | + | :[[Histiocytic sarcoma]] |
− | :Tumours derived from Langerhans cells | + | :[[Tumours derived from Langerhans cells]] |
− | :Langerhans cell histiocytosis | + | :[[Langerhans cell histiocytosis]] |
− | :Langerhans cell sarcoma | + | :[[Langerhans cell sarcoma]] |
− | :Interdigitating dendritic cell sarcoma | + | :[[Interdigitating dendritic cell sarcoma]] |
− | :Follicular dendritic cell sarcoma | + | :[[Follicular dendritic cell sarcoma]] |
− | :Other rare dendritic cell tumours | + | :[[Other rare dendritic cell tumours]] |
− | :Disseminated juvenile xanthogranuloma | + | :[[Disseminated juvenile xanthogranuloma]] |
| </div> | | </div> |
| </div> | | </div> |
Line 1,020: |
Line 1,019: |
| : [[Acute Lymphoblastic Leukaemia (ALL)]] | | : [[Acute Lymphoblastic Leukaemia (ALL)]] |
| : [[Acute Myeloid Leukaemia (AML)]] | | : [[Acute Myeloid Leukaemia (AML)]] |
− | ::[[Acute Megakaryoblastic Leukemia (AMKL)]] | + | ::[[HAEM5:Acute megakaryoblastic leukaemia]] |
| : [[Adrenal cortical carcinoma]] | | : [[Adrenal cortical carcinoma]] |
| : [[Anal Cancer]] | | : [[Anal Cancer]] |